Acrivon Therapeutics, Inc. Common Stock (ACRV) Ownership

$1.21

$0.01 (-0.82%)
Last update: 04:00 PM EST
Day's range
$1.18
Day's range
$1.24

Acrivon Therapeutics, Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 8.34 M $16.93 M   0.00% 21.81%
PERCEPTIVE ADVISORS LLC 05/15/2025 5.36 M $10.88 M   0.00% 14.02%
SANDS CAPITAL VENTURES, LLC 05/14/2025 2.12 M $4.31 M   0.00% 5.53%
CITADEL ADVISORS LLC 05/15/2025 1.90 M $3.85 M   -10.57% 4.94%
BLACKROCK, INC. 05/02/2025 938.71 K $1.91 M   -0.72% 2.45%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 888.13 K $1.80 M   0.00% 2.32%
VANGUARD GROUP INC 05/09/2025 674.79 K $1.37 M   0.47% 1.76%
MARSHALL WACE, LLP 05/15/2025 450.39 K $914.29 K   -24.66% 1.17%
05/19/2025 405.24 K $822.63 K   0.00% 1.06%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 306.11 K $621.58 K   1.57% 0.80%
STATE STREET CORP 05/15/2025 232.55 K $472.08 K   -1.71% 0.61%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 111.32 K $225.98 K   -2.21% 0.29%
NORTHERN TRUST CORP 05/13/2025 109.03 K $221.32 K   -7.07% 0.28%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 77.90 K $158.14 K   4.42% 0.20%
GOLDMAN SACHS GROUP INC 05/16/2025 57.52 K $116.76 K   -75.79% 0.15%
05/13/2025 56.47 K $114.63 K   420.10% 0.15%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 52.10 K $105.76 K   5.47% 0.14%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 44.15 K $89.99 K   19.13% 0.12%
INVESCO LTD. 05/12/2025 35.32 K $71.69 K   100.00% 0.09%
MORGAN STANLEY 05/15/2025 35.22 K $71.50 K   1.41% 0.09%
BARCLAYS PLC 05/15/2025 32.70 K $66.00 K   -14.16% 0.09%
BANK OF AMERICA CORP /DE/ 05/15/2025 27.70 K $56.23 K   -10.95% 0.07%
BANK OF NEW YORK MELLON CORP 04/29/2025 27.64 K $56.10 K   0.00% 0.07%
EXCHANGE TRADED CONCEPTS, LLC 04/17/2025 23.16 K $47.02 K   13.82% 0.06%
BAKER BROS. ADVISORS LP 05/15/2025 22.81 K $46.30 K   -56.87% 0.06%
AMERICAN CENTURY COMPANIES INC 05/13/2025 17.38 K $35.28 K   -1.18% 0.05%
RHUMBLINE ADVISERS 05/29/2025 16.60 K $33.69 K   -6.51% 0.04%
UBS OCONNOR LLC 05/15/2025 15.58 K $31.62 K   -84.85% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 14.58 K $29.60 K   100.00% 0.04%
05/12/2025 13.40 K $27.21 K   100.00% 0.03%
PRELUDE CAPITAL MANAGEMENT, LLC 05/15/2025 13.07 K $26.53 K   100.00% 0.03%
UBS GROUP AG 05/13/2025 12.89 K $26.16 K   -9.35% 0.03%
CITIGROUP INC 05/12/2025 11.16 K $22.65 K   -9.51% 0.03%
AAF WEALTH MANAGEMENT, LLC 05/16/2025 10.68 K $21.68 K   0.00% 0.03%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 10.09 K $20.49 K   100.00% 0.03%
JPMORGAN CHASE & CO 05/12/2025 8.48 K $17.21 K   -67.15% 0.02%
WELLS FARGO & COMPANY/MN 05/13/2025 7.09 K $14.39 K   2.26% 0.02%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 7.09 K $14.39 K   4.61% 0.02%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 04/30/2025 6.25 K $12.68 K   -5.41% 0.02%
COREBRIDGE FINANCIAL, INC. 05/14/2025 5.79 K $11.75 K   -1.46% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 3.09 K $6.27 K   74.97% 0.01%
FMR LLC 05/12/2025 2.67 K $5.41 K   -9.14% 0.01%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 2.31 K $5.00 K   0.00% 0.01%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 1.34 K $2.71 K   -31.17% 0.00%
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 04/24/2025 1.04 K $2.33 K   0.39% 0.00%
NISA INVESTMENT ADVISORS, LLC 04/30/2025 959 $1.95 K   859.00% 0.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 05/15/2025 856 $1.74 K   0.00% 0.00%
ROYAL BANK OF CANADA 05/15/2025 849 $2.00 K   -48.17% 0.00%
LEGAL & GENERAL GROUP PLC 05/15/2025 839 $1.70 K   0.00% 0.00%
STRS OHIO 05/28/2025 800 $1.62 K   0.00% 0.00%

Acrivon Therapeutics, Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 62 institutional investors and hedge funds held shares of Acrivon Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 8.34 M

PERCEPTIVE ADVISORS LLC: 5.36 M

Sands Capital Ventures, LLC: 2.12 M

CITADEL ADVISORS LLC: 1.9 M

BlackRock, Inc.: 938,707

WELLINGTON MANAGEMENT GROUP LLP: 888,130

58.71% of Acrivon Therapeutics, Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 23.11 M shares in the last 24 months. This purchase volume represents approximately $27.96 M in transactions.